about
Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stabilityAdjuvants: Classification, Modus Operandi, and LicensingChoice and Design of Adjuvants for Parenteral and Mucosal VaccinesAdvances in aluminum hydroxide-based adjuvant research and its mechanismHypothesis driven development of new adjuvants: short peptides as immunomodulatorsSynergistic activation of innate and adaptive immune mechanisms in the treatment of gonadotropin-sensitive tumorsTRIF is a critical negative regulator of TLR agonist mediated activation of dendritic cells in vivoSystematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble saltsOxidation by neutrophils-derived HOCl increases immunogenicity of proteins by converting them into ligands of several endocytic receptors involved in antigen uptake by dendritic cells and macrophagesVaccination of lactating dairy cows for the prevention of aflatoxin B1 carry over in milkExtracellular matrix from porcine small intestinal submucosa (SIS) as immune adjuvantsNeutrophil Extracellular Traps and MicrocrystalsNew adjuvanted vaccines in pregnancy: what is known about their safety?Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140.Serum cytokine profiles associated with specific adjuvants used in a DNA prime-protein boost vaccination strategy.A self-assembling peptide acting as an immune adjuvant.Lipid tucaresol as an adjuvant for methamphetamine vaccine development.Zebrafish fin immune responses during high mortality infections with viral haemorrhagic septicemia rhabdovirus. A proteomic and transcriptomic approach.Development of newborn and infant vaccinesHost immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxicationThe RTS,S vaccine candidate for malaria.Schistosoma mansoni soluble egg antigens enhance Listeria monocytogenes vector HIV-1 vaccine induction of cytotoxic T cellsOral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergyIntranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Animal models of allergic airways disease: where are we and where to next?Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells.MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens.Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice.Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid ARelative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial.Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum).Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccinesVaccination of heifers with anaflatoxin improves the reduction of aflatoxin b1 carry over in milk of lactating dairy cows.Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation.Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice.Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.Micrometer-sized titanium particles can induce potent Th2-type responses through TLR4-independent pathways
P2860
Q24634332-DFAB9CDD-1428-4F6D-A5F5-EEE7ED76CA61Q26747586-3D6D4BE7-C491-491A-87D1-7401A09A5EC8Q26783488-EAEF6720-4992-42D8-B04A-E2EE986D1842Q27007659-7B2C5755-AC80-4256-AAE1-CA1D06B74283Q27023844-70BDEA33-305C-49DC-8232-0208FE1267B0Q27324860-CDD0F8A4-3939-49E2-B6AA-A630B2244988Q27332276-74D7D53A-2D7D-49D0-B0D5-FC7EF56D5FB9Q28387541-49E05BE8-1BCF-4182-962D-48AA7FC9E8D4Q28391399-62A84EF9-7D5A-4AE7-86A3-02F79552CE04Q28477690-3E638BE0-6EDA-4776-8993-8535E79BC09DQ28743077-C32223B9-1A87-4C5E-96FF-A936D9CB8B41Q29248967-C2EBA354-A01A-43E2-9475-E68D0D5F8678Q30396657-290CFAA4-F924-43CC-8F76-B5556B524877Q31076192-00E83EAF-E49F-4970-A225-36C106763445Q31138173-F3FA455B-8BD9-4389-9631-31A13F959DFDQ33640064-07ED0121-0677-40A6-A99E-BD1D166D765BQ33662748-4B6AD987-2F82-4153-B56E-A37E708C9A86Q33704446-F8D6F3A1-F05E-435D-9DE1-E6F99C39C5F0Q33941914-115F6A86-0208-481F-AA6A-1C2C438A559EQ33990842-9A8D5195-56D8-4218-9B29-6F3060DAADE6Q34012394-B4C60427-02FE-4763-B4F4-AAF1B63D7FBAQ34186762-92AA0B62-1966-4A30-B1CC-826D4D0E4E83Q34260755-F368639C-B081-429B-BE65-A55DF1CB985EQ34291240-F6BF02FF-AC74-4635-B953-031078CFDC2EQ34309830-DB33650C-447E-478E-886B-9C88E4121293Q34353274-AE28D445-B396-44A2-8F40-D34A85BE111CQ34481835-18A37A12-A82B-4F34-B16B-54FCA32AA458Q34506918-30A97FAA-9994-4328-A692-999B10C6428CQ34524955-AC691D73-763A-445F-8FDB-D2D0DBC8BFDCQ34532064-EB2BA851-D861-451E-960F-882E942E4AD8Q34671882-253F6334-9EFB-4FA6-9E9D-89B58A4095C8Q34869353-DC241894-7804-438C-A847-A4074F84B57FQ34899535-B6BA668F-5035-4B76-B260-F07228C49864Q34993838-E4763E26-4F45-4B88-AC86-2E36C29A4FA2Q35100779-8A240C60-AEE1-4961-8351-E8CE41C4E23BQ35142810-05842DAD-8EC3-491F-8D00-BC5255FEE327Q35202632-9E6798B5-F18C-41AC-8756-AAAE8EBCD123Q35317663-46B7BDBA-B461-40D2-A76E-43F4F0D314AFQ35318380-51EC6EAF-6E21-4C52-9312-5972A0264805Q35613012-817241C4-FCDB-476F-A139-EA9243EB4675
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanism of action of clinically approved adjuvants.
@en
Mechanism of action of clinically approved adjuvants.
@nl
type
label
Mechanism of action of clinically approved adjuvants.
@en
Mechanism of action of clinically approved adjuvants.
@nl
prefLabel
Mechanism of action of clinically approved adjuvants.
@en
Mechanism of action of clinically approved adjuvants.
@nl
P2093
P1476
Mechanism of action of clinically approved adjuvants.
@en
P2093
Bart N Lambrecht
Mirjam Kool
Monique A M Willart
P356
10.1016/J.COI.2009.01.004
P577
2009-02-24T00:00:00Z